I thought this is very significant on page 3:
"
However, exploratory information from the Open Label extension phase suggests that for the cohort of 27 trial participants that completed all 24 months (11 from 15 that started IMAGINE on placebo together with 16 of 25 that remained on PBT2 for the 24 months), the amyloid levels decreased in this cohort compared to an historical control group from the Australian Imaging Biomarker and Lifestyle (AIBL) study. Although exploratory, the cohort data encourages exploration of changing brain amyloid in larger well powered trials "
Looks like they are seeing benefits in the extension trial results ... Looking forward to the paper !
- Forums
- ASX - By Stock
- ATH
- Ann: Appendix 4E and Annual Report 2015
Ann: Appendix 4E and Annual Report 2015, page-3
-
- There are more pages in this discussion • 33 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ATH (ASX) to my watchlist
|
|||||
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $18.62M |
Open | High | Low | Value | Volume |
0.3¢ | 0.4¢ | 0.3¢ | $886 | 275.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
48 | 56368671 | 0.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.4¢ | 125986200 | 26 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
47 | 56193671 | 0.003 |
51 | 82308098 | 0.002 |
25 | 120860100 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.004 | 125965200 | 25 |
0.005 | 29184782 | 27 |
0.006 | 12831477 | 17 |
0.007 | 47726651 | 22 |
0.008 | 22799732 | 22 |
Last trade - 11.34am 30/08/2024 (20 minute delay) ? |
Featured News
ATH (ASX) Chart |
The Watchlist
1CG
ONE CLICK GROUP LIMITED
Mark Waller, MD
Mark Waller
MD
Previous Video
Next Video
SPONSORED BY The Market Online